Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice

Virology

Volumn 255, Issue 2, 1999, Pages 221-227

  Deatly, Anne M ^a   Coleman, John W ^a   McMullen, Gail ^a   McAuliffe, Josephine M ^b   Jayarama, Vasudevacharya ^a   Cupo, Albert ^a   Crowley, Joan C ^a   McWilliams, Toya ^a   Taffs, Rolf E ^c  

^a PFIZER INC   (United States)

^b SUNY Dutchess Community College   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; FEMALE; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEX DIFFERENCE; VIRUS VIRULENCE;

ANIMALIA; DNA VIRUSES; MUS MUSCULUS; POLIOVIRUS;

EID: 0033558720     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9574     Document Type: Article

References (31)

1. Amrein H., Axel R. Genes expressed in neurons in adult male Drosophila. Cell. 88:1997;459-469.
2. Barton D. J., Black E. P., Flanegan J. B. Complete replication of poliovirusin vitro: J. Virol. 69:1995;5516-5527.
3. Bodian D. Emerging concept of poliomyelitis infection. Science. 122:1955;105-108.
4. Brownell B., Tomlinson A. H. Virus diseases of the central nervous system. Greenfield's Neuropathology. 1984;Wiley.
5. Chumakov K. M., Powers L. B., Noonan K. E., Roninson I. B., Levenbook I. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. USA. 88:1991;199-203.
6. Deatly A. M., Taffs R. E., McAuliffe J. M., Nawoschik S. P., Coleman J. W., McMullen G., Weeks-Levy C., Johnson A. J., Racaniello V. R. Characterization of mouse lines transgenic with the human poliovirus receptor gene. Microbiol. Pathol. 25:1998;43-54.
7. Dragunsky E., Taffs R., Chernokhvostova Y., Nomura T., Hioki K., Gardner D., Norwood L., Levenbook I. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine. Biologicals. 24:1996;77-86.
8. Furesz J., Contreras G. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines. Dev. Biol. Stand. 78:1993;61-70.
9. Gamarnik A. V., Andino R. Replication of poliovirus inXenopus. EMBO J. 15:1996;5988-5998.
10. Gelfand H. M., Holguin A. H. Enterovirus infections in healthy children. Study during 1960. Arch. Environ. Health. 5:1962;404-411.
11. Goodman L. Analyzing Qualitative/Categorical Data. Log-Linear Models and Latent Structure Analysis. 1978;Abt Associates Inc. Cambridge.
12. Gromeier M., Wimmer E. Mechanism of injury-provoked poliomyelitis. J. Virol. 72:1998;5056-5060.
13. Kalbfleisch J., Prentice R. The Statistical Analysis of Failure Time Data. 1980;Wiley.
14. Koike S., Aoki J., Nomoto A. Transgenic mouse for the study of poliovirus pathogenicity. Wimmer E., Weiss R. Cellular Receptors for Animal Viruses. 1994a;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
15. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iizuka N., Takeuchi K., Takegami T., Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:1990;3217-3224.
16. Koike S., Taya C., Aoki J., Matsuda Y., Ise I., Takada H., Matsuzaki T., Amanuma H., Yonekawa H., Nomoto A. Characterization of three transgenic mouse lines that carry human poliovirus receptor gene-influence of the transgene expression on pathogenesis. Arch. Virol. 139:1994;351-363.
17. Koike S., Ise I., Sato Y., Yonekawa H., Gotoh O., Nomoto A. A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J. Virol. 66:1992;7059-7066.
18. Lehman A., Sall J. JMP User's Guide. 1994;SAS Institute Inc, Cary.
19. WHO Bull. OMS. 71:1993;497-502.
20. Mendelsohn C. L., Wimmer E., Racaniello V. R. Cellular receptor for poliovirus. Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 56:1989;855-865.
21. Moore M. Enteroviral disease in the United States, 1970-1979. J. Infect. Dis. 146:1982;103-108.
22. Morens D. M., Pallansch M. A. Epidemiology. Rotbart H. A. Human Enterovirus Infections. 1995;Am. Soc. Microbiol. Washington.
23. Morens D. M., Pallansch M. A., Moore M. Polioviruses and other enteroviruses. Belshe R. B. Textbook of Human Virology. 1991;Mosby Year Book, St. Louis.
24. Nomoto A., Koike S., Aoki J. Tissue tropism and species specificity of poliovirus infection. Trends Microbiol. 2:1994;47-51.
25. Racaniello V. R., Ren R., Bouchard M. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis. Dev. Biol. Stand. 78:1993;109-116.
26. Racaniello V. R., Ren R. Transgenic mice and the pathogenesis of poliomyelitis. Arch. Virol. 9:1994;79-86.
27. Ren R., Racaniello V. R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166:1992;747-752.
28. Ren R., Constantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell. 63:1990;353-362.
29. Sabin A. B. Pathogenesis of poliomyelitis. Science. 123:1956;1151-1157.
30. Shanahan F. A gut reaction: Lymphoepithelial communication in the intestine. Science. 275:1997;1897-1898.
31. Yang W.-X., Terasaki T., Shiroki K., Ohka S., Aoki J., Tanabe S., Nomura T., Terada E., Sugiyama Y., Nomoto A. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology. 229:1997;421-428.